TITLE

Lanreotide

PUB. DATE
February 2016
SOURCE
Reactions Weekly;2/13/2016, Vol. 1588 Issue 1, p164
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a case study of a girl with neurofibromatosis type 1 and optic pathway glioma and diagnosed with growth hormone excess developing acute pancreatitis during treatment with lanreotide, and discontinuation of the lanreotide therapy.
ACCESSION #
112964830

 

Related Articles

  • Acromegaly, an endocrine disorder. Ross, Joel S.; Shua-Haim, Joshua R. // Geriatrics;May98, Vol. 53 Issue 5, p95 

    Focuses on a case study of an 80-year-old man who was diagnosed as having an endocrine disorder called acromegaly, which leads to enlargement of extremities. How the diagnosis for this condition is made; Age at which the condition mainly occurs; Types of treatments for the disorders.

  • Acromegaly. Danzig, Jon // BMJ: British Medical Journal (International Edition);10/20/2007, Vol. 335 Issue 7624, p824 

    A personal narrative is presented which explores the author's experiences of dealing with having the rare disease acromegaly.

  • Diagnosis and Treatment of Acromegaly. Maugans, Todd A.; Coates, Michael L. // American Family Physician;7/1/1995, Vol. 52 Issue 1, p207 

    Discusses the diagnosis of acromegaly. Illustrative case of a 49-year-old male with Gilbert's disease and cholelithiasis; Clinical characteristics; Somatomedins' role in the expansion of soft tissues in patients with acromegaly; Endocrinologic studies; Radiologic studies; Treatment of acromegaly.

  • Overheard about acromegaly. P.G.O'C. // Cortlandt Forum;02/25/98, Vol. 11 Issue 2, p88 

    Comments on a suggestion about the most diagnostic physical finding in acromegalics. Lack of data on the test characteristics of physical signs and symptoms in the diagnosis of acromegaly.

  • Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Lim, Michael J.; Barkan, Ariel L.; Buda, Andrew J.; Lim, M J; Barkan, A L; Buda, A J // Annals of Internal Medicine;11/1/92, Vol. 117 Issue 9, p719 

    Objective: To examine the possible role of growth hormone as a pathogenetic factor in the development of myocardial hypertrophy in acromegaly.Design: An uncontrolled clinical trial.Setting: Tertiary-care medical center.Patients: Sixteen...

  • Medical Progress: Acromegaly.  // New England Journal of Medicine;2/22/2007, Vol. 356 Issue 8, p879 

    A correction to the article "Medical Progress: Acromegaly" that was published in the December 14, 2006 issue is presented.

  • acromegaly.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p34 

    An encyclopedia entry for "acromegaly," which is a syndrome of excessive secretion of growth hormone, is presented.

  • Acromegaly and cancer. Klein, Irwin; Klein, I // Annals of Internal Medicine;Nov84, Vol. 101 Issue 5, p706 

    Editorial. Focuses on the association between acromegaly and cancer. Reasons for the difficulty in assessing incidence rates; Speculations on the cause of increase in malignancy.

  • Acromegaly with Normal Fasting Growth Hormone Concentrations but Abnormal Growth Hormone Regulation. Mims, Robert B.; Bethune, John E. // Annals of Internal Medicine;Dec74, Vol. 81 Issue 6, p781 

    Focuses on a study which evaluated growth hormone dynamics in patients with acromegaly. Clinical and laboratory features of acromegalic patients; Materials and methods used for the study; Findings.

  • Doctor's perspective. Cohen, Stephen // BMJ: British Medical Journal (International Edition);10/20/2007, Vol. 335 Issue 7624, p825 

    The article presents a personal narrative of the author's involvement in attempting to find the diagnosis of acromegaly in a patient.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics